drugset / Trial / NCT00385944

The Effect on Blood Cells, Known as Platelets, Using Prasugrel vs Clopidogrel in Patients With the Heart Problem Acute Coronary Syndrome (ACS)

NCT00385944

Phase 2 Completed 56 enrolled Eli Lilly and Company Daiichi Sankyo · collab
RandomizedCrossoverQuadruple-blindTreatment

Summary

This is a multicenter, randomized, double-blind, cross-over study to compare the pharmacodynamic response in subjects with Acute Coronary Syndrome receiving a 10-mg maintenance dose (MD) of prasugrel compared with a 150-mg maintenance dose of clopidogrel, following a 900-mg loading dose (LD) of clopidogrel.

Timeline

Start
2007-03
Primary completion
2007-10
Completion
2007-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Clopidogrel Small molecule 150 mg Oral
Subject Prasugrel Small molecule 10 mg Oral